Navigation Links
NeoStem Announces Proposed Public Offering of Common Stock
Date:7/18/2011

NEW YORK, July 18, 2011 /PRNewswire/ -- NeoStem, Inc., (NYSE-Amex: NBS) today announced that it intends to offer and sell shares of its common stock and warrants in an underwritten public offering. All of the shares and warrants in the offering will be sold by NeoStem. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares will be issued pursuant to a prospectus supplement filed as part of an effective shelf registration statement previously filed with the Securities and Exchange Commission (SEC) on Form S-3.

Lazard Capital Markets, LLC and JMP Securities are acting as joint book-runners of the offering.  Morgan Joseph TriArtisan LLC, Maxim Group LLC and National Securities Corporation are acting as co-managers of the offering.

A shelf registration statement relating to the shares was filed with the Securities and Exchange Commission and is effective. A preliminary prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC's website located at www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, from Lazard Capital Markets LLC, 30 Rockefeller Plaza, 60th Floor, New York, NY 10020 or via telephone at (800) 542-0970.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. NeoStem intends to file a preliminary prospec
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
2. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
3. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
4. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
5. NeoStem to Present at 10th Annual Needham Healthcare Conference on Tuesday, April 5
6. NeoStem Provides Results for 2010 and an Update on Recent Activities
7. NeoStem To Present at Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8
8. NeoStem to Launch New Service and Has Engaged Healthcare Personality Dr. Manny Alvarez to Serve as Spokesperson
9. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
10. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
11. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 Hill-Rom,s recent ... $2 billion in cash and stock means the ... market, according to Kalorama Information. The healthcare market ... the medical device and advanced wound care markets, ... beds, patient lifting devices, and other healthcare equipment. ...
(Date:7/7/2015)... , July 7, 2015  Shareholder rights law ... a federal securities fraud class action complaint was ... Southern District of California.  The complaint alleges that ... CLDN ) violated the Securities Exchange Act of ... 2015, by making materially false and misleading statements ...
(Date:7/7/2015)... 7, 2015 According to ... Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, ... Alpha Emitters, Brachytherapy - Y-90), by Application (Oncology, ... by MarketsandMarkets, this report studies the global Nuclear ... to 2020. This market is expected to reach ...
Breaking Medicine Technology:Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 2Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading provider ... VA Series virtual appliances. These virtual platforms expand the existing physical appliances ... proven to simplify the on-premises deployment of unified remote access and single sign-on ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... global provider of advanced delivery technologies and development solutions for drugs, biologics ... licensing agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) ...
(Date:7/7/2015)... ... 2015 , ... The Immune Deficiency Foundation (IDF) launched a ... its IDF ePHR, an electronic personal health record powered by Get Real Health’s ... their health information, including symptoms, diagnoses, medications, infusions and other critical health data. ...
(Date:7/7/2015)... ... July 07, 2015 , ... On ... was the site of the National Baptist Convention 110th Annual Session of the ... and promoting the collaboration of churches and their congregations, medical professionals and health-related ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri ... whitening treatments. A professional teeth whitening is one of the fastest, easiest ways to ... as they can decrease smile satisfaction and confidence. With the right teeth whitening treatment, ...
Breaking Medicine News(10 mins):Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3
... dead, without government ... Americans, DES MOINES, Iowa, Dec. 10 Print ads ... Nurses,Association (CNA)/National Nurses Organizing Committee (NNOC) is running,the ads as ... for all Americans through a Medicare-based system., The ad ...
... to Head Department, BANNOCKBURN, Ill., Dec. ... a contract research organization serving,pharmaceutical and biotechnology ... Wozniak, Ph.D., as Director, Statistical Programming. Dr.,Wozniak ... ACRS facilitates successful clinical trials by ...
... the Medicare End Stage Renal Disease Program Recommends,Policy ... Awareness, WASHINGTON, Dec. 10 The Association ... today,released a consensus report addressing proposed changes to ... are currently being considered by,the U.S. Congress., ...
... challenges traditional assessment of risk , , MONDAY, Dec. 10 ... at low risk for heart disease still face potential ... a new study suggests. , "Previous studies have demonstrated ... other populations," said study lead author Dr. Susan G. ...
... higher than dentists do, according to a new study. Teeth ... attractive face, the study also found, and people younger than ... published in this months Journal of the American Dental Association ... smiles on a 100-point satisfaction scale. Later, the patients regular ...
... and Nexium , , MONDAY, Dec. 10 (HealthDay News) ... heartburn drugs Prilosec and Nexium found no evidence of ... announcement followed a three-month safety review after reports of ... detailed data from both studies, plus another 14 studies, ...
Cached Medicine News:Health News:RNs Sponsor Hard-Hitting Health Care Ads in Top 10 Iowa Papers 2Health News:Advanced Clinical Research Services Enhances Biostatistics Offering 2Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 2Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 3Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 4Health News:Coronary Artery Calcium May Raise Women's Heart Risk 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 3
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: